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Abstract
Flickering light stimulation of retinal photoreceptors induces retinal vessel dilation in humans. In the present study the eﬀect of
high blood glucose levels on this neuro-vascular mechanism was investigated in 12 healthy young male subjects. Blood glucose levels
were consecutively increased during 30 min to 100, 200 and 300 mg/dl and kept at the respective level for the following 30 min using
hyperglycemic insulin clamps. Eight Hertz ﬂickering light was applied to the fundus at the end of each glucose plateau during
continuous retinal vessel diameter measurements with the Zeiss retinal vessel analyser (RVA). During normoglycemia (100 mg/dl)
ﬂickering light induced a signiﬁcant vasodilation of retinal arteries (+2.8 0.4%, p < 0:0001) and veins (+2.6 0.4%, p < 0:0001).
At 300 mg/dl blood glucose the ﬂicker response in retinal veins was signiﬁcantly decreased by 55% (p ¼ 0:015 versus 100 mg/dl). The
modiﬁed RVA employed in the present study provides high sensitivity and is capable of studying ﬂicker-induced retinal vasodi-
lation. Using this technique the present study conﬁrms that ﬂickering light stimulation of the human retina induces vasodilation in
retinal vessels in healthy subjects. In addition, our data indicate that the retinal vessel response to ﬂickering light stimulation is
signiﬁcantly reduced during hyperglycemia in humans. The relevance of this ﬁnding for diabetes-related eye disease remains to be
shown.
 2003 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Previous studies have demonstrated that increases in
retinal neuronal activity are associated with increases in
retinal metabolism and blood ﬂow (Buerk, Riva, &
Cranstoun, 1995; Formaz, Riva, & Geiser, 1979; Kiryu,
Asrani, Shahidi, Mori, & Zeimer, 1995; Riva, Harino,
Shonat, & Petrig, 1991; Scheiner, Riva, Kazahaya, &
Petrig, 1994; Van Toi & Riva, 1995). Flickering light
stimulation of the human fundus increases the activity
of retinal ganglion cells, causing a release of local va-
sodilating factors. The subsequent increase in retinal
and optic nerve head blood ﬂow has been measured
in cats, primates and humans with diﬀerent methods
(Buerk et al., 1995; Kiryu et al., 1995; Riva, Cranstoun,
Mann, & Barnes, 1994; Riva, Cranstoun, & Petrig, 1996;
Riva et al., 1991; Scheiner et al., 1994; Van Toi & Riva,
1995; Wang & Bill, 1997) but the mechanisms involved
in retinal neuro-vascular response are not entirely clear.
We have recently introduced a method which allows
for online measurement of retinal vessel diameters dur-
ing ﬂicker stimulation based on a commercially available
retinal vessel analyser (RVA). Using this technique reti-
nal vasodilation in response to diﬀuse luminance ﬂick-
ering light can be investigated with high reproducibility.
This allows for investigations into the mechanisms un-
derlying retinal vasodilation and for interventions which
may possibly alter the response. In the present study the
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vessel response to ﬂickering light was investigated during
diﬀerent levels of hyperglycemia in a group of healthy
young subjects. This was done in an eﬀort to gain more
insight into retinal blood ﬂow dysregulation in diabetes
(Bursell et al., 1996; Schmetterer & Wolzt, 1999).
2. Methods
After approval of the study protocol by the Ethics
Committee of the Vienna University School of Medicine
and after written informed consent was obtained, 12
healthy, non-smoking (nicotine absence P 5 years),
drug-free male volunteers between 23 and 29 years of
age (mean SD: 25.0 2.1 years) were enrolled in the
study.
A screening examination was passed by all subjects
including medical history, a physical examination, 12-
lead electrocardiogram, complete blood tests, an oral
glucose tolerance test, urine analysis, and an urine drug-
screening. An ophthalmic examination had to be normal
in all subjects. Ametropia of less than 3 diopters, and
anisometropia of less than 1 diopter was a prerequisite.
Subjects were asked to refrain from alcohol and caf-
feine for at least 12 h before the study day. The study
was performed after an overnight fast in a quiet room
with an ambient temperature of 22 C that had complete
resuscitation facilities. Baseline systemic hemodynamics
were reached within 30 min, which was veriﬁed by re-
peated blood pressure monitoring.
2.1. Study design
The study was performed on two separate study days
in a two way cross over design. The person evaluating
the recordings of the RVA and the participating subjects
were masked regarding intravenous treatments. On one
study day a hyperglycemic insulin clamp according to
De Fronzo, Tobin, and Andress (1997) was performed.
During this hyperglycemic insulin clamp endogenous
insulin production is blocked by a continuous soma-
tostatin infusion (Somatostatin UBC Pharma, Vienna,
Austria; 0.1 lg/kg/min for 210 min, dose reference:
Roden et al. (1996)), and insulin (Huminsulin ‘‘Lilly’’,
Eli Lilly, Vienna, Austria) is co-infused at 0.1 mU/kg/
min to substitute basal insulin. With this technique
blood glucose can be increased to predeﬁned levels at
physiological insulin plasma levels. This is important,
because in healthy humans both insulin and glucose
increase ocular blood ﬂow (Luksch et al., 2001). In the
present study the glucose plasma level was set to 100,
200 and 300 mg/dl by adapting the infusion rate of a
20% glucose infusion (Glucose 20% ‘‘Mayrhofer’’, Mayr-
hofer Pharmaceuticals, Linz, Austria). Each glucose
level was calibrated within 30 min and kept for the
following 30 min. On the other study day a comparable
amount of physiologic saline solutions was infused to
guarantee masked conditions.
2.2. Zeiss retinal vessel analyser
The Zeiss RVA is a commercially available system
which comprises a fundus camera (Zeiss FF 450, Jena,
Germany), a video camera, a real time monitor and
a personal computer with an analyzing software for
accurate determination of retinal arterial and venous
vessel diameters (Vilser et al., 1997). Retinal vessel di-
ameters are analysed in real time at 50 Hz, obtaining 25
vessel diameter readings per second. The fundus image is
recorded by a video camera, digitised using a frame
grabber and displayed on a real time monitor. Simul-
taneously, the signal is stored on a video tape, allowing
oﬀ-line re-analyses of diﬀerent vessel diameters.
Each blood vessel has a speciﬁc transmittance proﬁle
due to the absorbing properties of hemoglobin. The
software of the RVA calculates retinal vessel diameters
with adaptive algorithms using these speciﬁc proﬁles.
Whenever a speciﬁc vessel proﬁle is recognised the RVA
is able to follow this vessel as long as it appears within
the measurement window. This means that the system is
able to automatically correct for alterations in lumi-
nance as induced for instance by slight eye movements.
If the requirements for the assessment of retinal vessel
diameters are not fulﬁlled anymore, as it occurs during
blinks, the system automatically stops the measurement
of vessel diameter. As soon as an adequate fundus image
is achieved again, measurement of vessel diameters re-
starts automatically.
To select a region of interest the user deﬁnes a rect-
angle on the screen of the real time monitor. This win-
dow can either include a retinal artery or a retinal vein
or both. Thereafter the measurement of vessel diameters
can be started. Retinal vessel diameter is then calculated
along the arterial or venous segment, which lies within
the rectangle.
2.3. Measurement of blood glucose
Blood glucose was measured every 5–10 min from
arterialized venous blood samples using a Beckman
glucose analyser (Beckman Coulter, Inc. Fullerton, CA,
USA). For this purpose the contralateral arm, which
was not used for intravenous drug administration was
placed in a heating box.
2.4. Flicker stimulus with a Grass PS-2 photo stimula-
tion model
Before drug infusion and at the end of each infusion
period retinal vessel diameters were continuously mea-
sured for 352 s. Diﬀuse luminance ﬂickering light was
applied consecutively for 16, 32 and 64 s at a frequency
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of 8 Hz during measurements with the RVA. Before and
after each ﬂicker period 60 s of baseline recordings were
scheduled (Fig. 1). In order to avoid that the ﬂickering
light interferes with the fundus recordings using the
Zeiss RVA the light of the fundus camera and the light
used for ﬂicker stimulation had to be separated. A
wavelength separation technique was used for this pur-
pose: One interference ﬁlter with a centre wavelength of
590 nm and a bandwidth of 10 nm was introduced in the
illumination pathway of the fundus camera. Hence, the
eye was illuminated with light containing wavelengths
between 580 and 600 nm. In this wavelength range the
contrast between blood vessels and the surrounding
tissue is optimal. A matching interference ﬁlter was
placed in front of the video camera used for fundus re-
cordings. This ensures that only light consisting of the
wavelength used for illumination is seen by the video
camera.
For ﬂicker stimulation white light in combination
with a 550 nm low pass cut-oﬀ ﬁlter was used. This
ensures that light with a wavelength below 550 nm is
used for stimulation. This light was directly coupled to
the illumination pathway of the fundus camera. Hence,
the light used for ﬂicker stimulation does not pass to the
video camera but is perceived by the subject under
study. This ensures constant illumination at the fundus
image, a prerequisite for adequate vessel diameter
measurement. The ﬂicker was centred in the macula with
an angle of approximately 30. All measured vessel
segments were within 1–2 disc diameters from the mar-
gin of the optic disc and within the area illuminated with
ﬂickering light. The illumination light of the fundus
camera was kept at the lowest possible intensity in order
to increase the contrast to the ﬂickering light. This
was achieved by a retinal irradiance of approximately
220 lW/cm2. The ﬂash intensity was set to 16 on the
control unti of the Grass PS-2 photo stimulator. The
coeﬃcient of variation of the ﬂicker responses is less
than 25% (Polak, Schmetterer, & Riva, 2002).
2.5. Data analysis
The mean retinal vessel diameter as averaged from 10 s
preceding the start of the ﬂicker stimulation was deﬁned
as the baseline diameter. These values were taken to
assess the eﬀect of blood glucose on retinal vessel di-
ameters as well as to calculate the response to ﬂicker
stimulation. The ﬂicker response was deﬁned as the
diﬀerence between the last 10 s of the ﬂicker period and
the pre-ﬂicker vessel diameter, and was expressed as %
change from baseline.
For data description results are presented as means
SEM. The eﬀect of glucose and ﬂickering light on the
outcome variables was assessed with a repeated measure
ANOVA model. Eﬀects of ﬂicker stimulation on retinal
vessel diameters were tested versus the pre-ﬂicker values.
Eﬀects of hyperglycemia on the outcome parameters
were tested versus placebo. A two tailed p ¼ 0:05 was
considered the level of signiﬁcance.
3. Results
The insulin clamp was well tolerated by all 12
subjects. Systemic hemodynamics remained constant
throughout both study days (Table 1). Baseline vessel
diameters are presented in Table 1. The increase in
blood glucose had no consistent eﬀect on retinal arterial
and venous vessel diameter. On the clamp day mean
blood glucose plasma levels immediately before RVA
measurements were 100 2 mg/dl (mean SEM, at
step 1), 210 4 mg/dl (step 2) and 306 2 mg/dl (step 3),
respectively.
A sample measurement of a retinal venous diameter
during ﬂickering light stimulation is presented in Fig. 1.
On the placebo day stimulation with ﬂickering light in-
creased retinal venous and arterial diameters between
1.8% and 2.7% versus baseline (p < 0:0001; ANOVA,
Table 2). The ﬂicker response was comparable with 16,
32 and 64 s of stimulation. Placebo had no signiﬁcant
eﬀect on ﬂicker responses in retinal arteries or veins.
On the clamp study day ﬂicker stimulation increased
venous vessel diameters at 100 mg/dl blood glucose by
+2.0 0.4%, +2.5 0.6% and +2.6 0.4% and arterial
vessel diameters by +2.7 0.4%, +2.9 0.6% and
+2.8 0.4% during 16, 32 and 64 s of ﬂicker stimulation,
respectively. These ﬂicker responses were comparable to
those seen on the placebo day.
In retinal arteries hyperglycemia at plasma glucose
levels of 200 and 300 mg/dl did not signiﬁcantly change
the response of retinal vessel diameters during ﬂickering
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Fig. 1. Sample measurement of retinal venous diameter during ﬂicker
stimulation. Flicker periods (16, 32 and 64 s) are marked with vertical
bars. 60 s of baseline measurements were scheduled between each
ﬂicker period.
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light stimulation. A tendency towards reduced ﬂicker
responses in arteries was, however, seen. At 300 mg/dl
the increase in retinal arterial diameters was 21% (16 s of
ﬂicker), 30% (32 s of ﬂicker) and 6% (64 s of ﬂicker)
smaller than at plasma glucose levels of 100 mg/dl
(p ¼ ns; ANOVA; Table 3).
In retinal veins the increase in blood glucose to 200
mg/dl had no signiﬁcant eﬀect on the increase of diam-
eters during ﬂicker stimulation. In contrast, 300 mg/dl
signiﬁcantly decreased the ﬂicker response in retinal
veins by 55% (16 s of ﬂicker, p ¼ 0:015 versus 100 mg/dl,
ANOVA), by 51% (32 s of ﬂicker, p ¼ 0:015 versus 100
mg/dl, ANOVA) and by 37% (64 s of ﬂicker, p ¼ 0:023;
ANOVA versus 100 mg/dl) at the three ﬂicker periods,
respectively.
4. Discussion
We present a method which allows for real time
measurement of retinal vessel diameters during ﬂicker
stimulation in humans. Using this novel approach the
data of the present study indicate that hyperglycemia
reduces ﬂicker-induced vasodilation in human retinal
branch veins.
There is now convincing evidence that the increase in
retinal and optic nerve blood ﬂow in response to ﬂicker
stimulation is a direct consequence of retinal neural
activity. On the one hand the increase in optic nerve
head blood ﬂow shows similar characteristics as com-
Table 1
Baseline systemic hemodynamics and baseline vessel diameters of both study days (n ¼ 12)
Blood glucose levels Clamp day Control day ANOVA
100 mg/dl 200 mg/dl 300 mg/dl
Mean arterial blood pressure
(mmHg) before ﬂicker
79.1 3.3 79.2 3.0 79.2 2.7 80.2 3.7 n.s.
Mean arterial blood pressure
(mmHg) after ﬂicker
78.9 3.0 79.3 2.7 78.7 3.3 79.7 2.5 n.s.
Pulse rate (bpm) before ﬂicker 63.1 2.7 57.9 1.6 58.2 1.4 60.2 0.4 n.s.
Pulse rate (bpm) after ﬂicker 65.7 3.6 60.7 2.5 58.4 3.4 58.9 2.7 n.s.
Arterial vessel diameter before
ﬂicker (lm)
16 s 118.4 6.1 116.5 6.3 117.4 6.3 117.3 4.2 n.s.
32 s 116.8 6.3 117.4 6.4 118.4 6.6 117.8 5.3 n.s.
64 s 117.6 6.2 116.8 6.8 118.1 6.3 118.6 4.1 n.s.
Venous vessel diameter before
ﬂicker (lm)
16 s 136.4 4.7 135.9 4.7 135.9 4.7 137.0 5.7 n.s.
32 s 135.7 4.4 135.7 4.6 135.1 4.5 135.7 3.4 n.s.
64 s 136.5 4.6 136.0 4.7 135.1 4.5 135.5 5.6 n.s.
ANOVA describes signiﬁcance between control (placebo) and clamp study day.
Table 2
Control day: % increase of retinal vessel diameters during ﬂickering
light stimulation (n ¼ 12)
Placebo infusions Step 1 Step 2 Step 3
Veins
16 s ﬂicker +1.9 0.3 +2.3 0.8 +1.8 0.4
32 s ﬂicker +2.5 0.6 +1.8 0.5 +1.8 0.2
64 s ﬂicker +2.3 0.7 +2.0 0.7 +2.2 0.6
Arteries
16 s ﬂicker +2.6 0.4 +1.9 0.4 +1.7 0.3
32 s ﬂicker +2.2 0.5 +2.5 0.8 +2.4 0.5
64 s ﬂicker +2.1 0.4 +3.0 0.7 +2.7 0.9
Means SEM were calculated from the last 10 s of each ﬂicker stim-
ulation period.
Flickering light stimulation signiﬁcantly increased retinal arterial
and venous vessel diameters (p < 0:0001, ANOVA); this eﬀect was
comparable between all infusion steps and ﬂicker lengths (16, 32 and
64 s).
Table 3
Clamp day: % change of retinal vessel baseline diameters during ﬂickering light stimulation at 100, 200 and 300 mg/dl blood glucose (n ¼ 12)
Glucose infusions 100 mg/dl 200 mg/dl ANOVA 100 versus
200
300 mg/dl ANOVA 100 versus
300
Veins
16 s ﬂicker +2.0 0.4 +1.9 0.3 n.s. +0.8 0.2 p < 0:015
32 s ﬂicker +2.5 0.6 +2.5 0.6 n.s. +1.2 0.3 p < 0:015
64 s ﬂicker +2.6 0.4 +2.4 0.3 n.s. +1.6 0.3 p < 0:023
Arteries
16 s ﬂicker +2.7 0.4 +2.2 0.3 n.s. +2.0 0.5 n.s. (p ¼ 0:40)
32 s ﬂicker +2.9 0.6 +2.4 0.4 n.s. +1.9 0.5 n.s. (p ¼ 0:3)
64 s ﬂicker +2.8 0.4 +2.8 0.5 n.s. +2.6 0.3 n.s. (p ¼ 0:65)
Means SEM were calculated from the last 10 s of each ﬂicker stimulation period.
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pared to ganglion cell spiking when plotted as a function
of ﬂicker-frequency, modulation depth and relative
chromaticity (Riva, Falsini, & Logean, 2001). On the
other hand the response in optic nerve head blood ﬂow
during ﬂicker stimulation is similar and directly corre-
lated to the ﬁrst and second harmonic amplitudes of the
ﬂicker electroretinogram (Falsini, Riva, & Logean,
2002). Whereas these results show that retinal and optic
nerve head blood ﬂow changes in response to ﬂickering
light stimulation are a consequence of retinal neural
activity (Falsini et al., 2002), the mechanisms underlying
vasodilation are unclear.
Previous animal studies have shown that ﬂicker
stimulation alters retinal glucose metabolism. Wang and
Bill (1997) have revealed that in the cat up to 80% of the
glucose is metabolised in the retina by aerobic lactate
production. The same group has shown that in rabbits
retinal glucose consumption and lactate formation in-
creases by approximately 15–20% during ﬂicker stimu-
lation (Wang, Kondo, & Bill, 1997). This appears to be
related to the changes in ocular perfusion, because
plasma lactate and plasma pyruvate modulate ﬂicker-
induced retinal blood ﬂow changes in the rat (Ido,
Chang, Woolsey, & Williamson, 2001).
To ﬁnally answer the question how hyperglycemia and
ﬂicker-induced vasodilation interact data from the reti-
nal microvasculature are required, but there is a lack
of methods for real time assessment of human retinal
microvessels in vivo. This problem also applies for the
Zeiss RVA and vessels which have a diameter below
20 lm and contribute most to vascular resistance, cannot
be measured due to the limited resolution of the tech-
nique. In principle such information may also be gained
from measurements of retinal blood velocity using bi-
directional laser Doppler velocimetry allowing for cal-
culation of total retinal blood ﬂow (Riva, Grunwald,
Sinclair, & Petrig, 1985). However, to obtain reproduc-
ible ﬂicker responses with this system is diﬃcult, because
excellent target ﬁxation is required. Interestingly, hyper-
glycemia at 300 mg/dl plasma glucose reduced the ﬂic-
ker response in veins but not in arteries. This may either
be related to diﬀerences in the mechanism underlying
ﬂicker-induced vasodilation or more likely indicates in-
teraction between the ﬂicker response and hyperglycemia
at the level of the retinal microvasculature.
Our study is, however, well compatible with numerous
previous reports indicating vasoactive properties of glu-
cose in the eye and retinal vascular dysregulation in di-
abetes. Various animal (Atherton, Hill, Keen, Young, &
Edwards, 1980; Ernest, Goldstick, & Engerman, 1983;
Sullivan, Davies, Caldwell, Morris, & Kohner, 1990) and
human studies (Luksch et al., 2001) have shown that
glucose increases ocular blood ﬂow. Sullivan et al. (1990)
revealed that hyperglycemia increases retinal blood ﬂow
by increasing retinal blood velocity without aﬀecting
retinal branch vein diameters. This is in keeping with the
results of the present study where no eﬀect on basal
retinal arterial and venous diameters was seen at plasma
glucose concentrations of 300 mg/dl. Retinal perfusion
abnormalities in patients with diabetes are complex and
largely depend on the stage of diabetic retinopathy.
There is, however, evidence that early stages of diabetic
retinopathy are associated with increased retinal blood
ﬂow and retinal vasodilation (Falck & Laatikainen,
1995; Grunwald, Du Pont, & Riva, 1996; Grunwald,
Riva, Sinclair, Brucker, & Petrig, 1986; Patel, Rassam,
Newsom, Wiek, & Kohner, 1992) associated with an
abnormal retinal vascular response to hyperoxia (Grun-
wald, Riva, Petrig, Sinclair, & Brucker, 1984; Patel,
Rassam, Chen, & Kohner, 1994) and abnormal retinal
autoregulation (Rassam, Patel, & Kohner, 1995; Sinclair
et al., 1982).
One potential limitation of the present study is that
hyperglycemia reduced neuronal activity during ﬂicker
stimulation rather than aﬀecting neuro-vascular cou-
pling. This is, however, unlikely because there is no ev-
idence that acute hyperglycemia aﬀects visual evoked
potentials in patients with type I diabetes (Martinelli
et al., 1992).
In conclusion, the modiﬁed RVA as employed in the
present study is capable of studying ﬂicker responses in
retinal arteries and veins. The reproducibility of this
response to ﬂicker stimulation is adequate to study po-
tential mechanisms underlying this eﬀect. Using this
technique, we have shown that hyperglycemia reduces
the response of retinal veins to ﬂicker stimulation. The
relevance of this ﬁnding for diabetes associated eye
disease remains to be shown.
Acknowledgement
Financial support from Jubil€aumsfonds der €Osterrei-
chischen Nationalbank (# 8395) is gratefully acknowl-
edged.
References
Atherton, A., Hill, D. W., Keen, H., Young, S., & Edwards, E. J.
(1980). The eﬀect of acute hyperglycaemia on the retinal circulation
of the normal cat. Diabetologia, 18, 233–237.
Buerk, D. G., Riva, C. E., & Cranstoun, S. D. (1995). Frequency and
luminance-dependent blood ﬂow and K+ ion changes during
ﬂicker stimuli in cat optic nerve head. Investigative Ophthalmology
and Visual Science, 36, 2216–2227.
Bursell, S. E., Clermont, A. C., Kinsley, B. T., Simonson, D. C.,
Aiello, L. M., & Wolpert, H. A. (1996). Retinal blood ﬂow changes
in patients with insulin-dependent diabetes mellitus and no diabetic
retinopathy. Investigative Ophthalmology and Visual Science, 37,
886–897.
De Fronzo, R. A., Tobin, J. D., & Andress, R. (1997). Glucose clamp
technique: a method for quantifying insulin secretion and resis-
tance. American Journal of Physiology, 237, E214–E223.
Ernest, J. T., Goldstick, T. K., & Engerman, R. L. (1983).
Hyperglycaemia impairs retinal oxygen autoregulation in normal
G.T. Dorner et al. / Vision Research 43 (2003) 1495–1500 1499
and diabetic dogs. Investigative Ophthalmology and Visual Science,
24, 985–989.
Falck, A., & Laatikainen, L. (1995). Retinal vasodilation and
hyperglycemia in diabetic children and adolescents. Acta Ophthal-
mologica, 73, 119–124.
Falsini, B., Riva, C. E., & Logean, E. (2002). Flicker-evoked changes
in human optic nerve blood ﬂow: relationship with retinal neural
activity. Investigative Ophthalmology and Visual Science, 43, 2309–
2316.
Formaz, F., Riva, C. E., & Geiser, M. (1979). Diﬀuse luminance ﬂicker
increases retinal vessel diameter in humans. Current Eye Research,
16, 1252–1257.
Grunwald, J. E., Du Pont, J., & Riva, C. E. (1996). Retinal
haemodynamics in patients with early diabetes mellitus. British
Journal of Ophthalmology, 80, 327–331.
Grunwald, J. E., Riva, C. E., Petrig, B. L., Sinclair, S. H., & Brucker,
A. J. (1984). Eﬀect of pure O2-breathing on retinal blood ﬂow in
normals and in patients with background diabetic retinopathy.
Current Eye Research, 3, 239–241.
Grunwald, J. E., Riva, C. E., Sinclair, S. H., Brucker, A. J., & Petrig,
B. L. (1986). Laser Doppler velocimetry study of retinal circulation
in diabetes mellitus. Archives of Ophthalmology, 104, 991–996.
Ido, Y., Chang, K., Woolsey, T. A., & Williamson, J. R. (2001).
NADH: sensor of blood ﬂow need in brain, muscle, and other
tissues. The FASEB Journal, 15, 1419–1421.
Kiryu, J., Asrani, S., Shahidi, M., Mori, M., & Zeimer, R. (1995).
Local response of the primate retinal microcirculation to increased
metabolic demand induced by ﬂicker. Investigative Ophthalmology
and Visual Science, 36, 1240–1246.
Luksch, A., Polak, K., Matulla, B., Dallinger, S., Kapiotis, S., Rainer,
G., Wolzt, M., & Schmetterer, L. (2001). Glucose and insulin exert
additive ocular and renal vasodilator eﬀects on healthy humans.
Diabetologia, 44, 95–103.
Martinelli, V., Piatti, P. M., Filippi, M., Pacchioni, M., Pastore, M. R.,
Canal, N., & Comi, G. (1992). Eﬀects of hyperglycaemia on visual
evoked potentials in insulin-dependent diabetic patients. Acta
Diabetologica, 29, 34–37.
Patel, V., Rassam, S. M. B., Chen, H. C., & Kohner, E. M. (1994).
Oxygen reactivity in diabetes mellitus: eﬀect of hypertension and
hyperglycaemia. Clinical Science, 86, 689–695.
Patel, V., Rassam, S., Newsom, R., Wiek, J., & Kohner, E. (1992).
Retinal blood ﬂow in diabetic retinopathy. British Medical Journal,
305, 678–683.
Polak, K., Schmetterer, L., & Riva, C. E. (2002). Inﬂuence of ﬂicker
frequency on ﬂicker-induced changes of retinal vessel diameter.
Investigative Ophthalmology and Visual Science, 43, 2721–2726.
Rassam, S. M. B., Patel, V., & Kohner, E. M. (1995). The eﬀect of
experimental hypertension on retinal vascular autoregulation in
humans: a mechanism for the progression of diabetic retinopathy.
Experimental Physiology, 80, 53–68.
Riva, C. E., Cranstoun, S. D., Mann, R. M., & Barnes, G. E. (1994).
Local choroidal blood ﬂow in the cat by laser Doppler ﬂowmetry.
Investigative Ophthalmology and Visual Science, 35, 608–618.
Riva, C. E., Cranstoun, S. D., & Petrig, B. L. (1996). Eﬀect of
decreased ocular perfusion pressure on blood ﬂow and the ﬂicker-
induced ﬂow response in the cat optic nerve head. Microvascular
Research, 52, 258–269.
Riva, C. E., Falsini, B., & Logean, E. (2001). Flicker evoked response
of human optic nerve head blood ﬂow: luminance versus chromatic
modulation. Investigative Ophthalmology and Visual Science, 42,
756–762.
Riva, C. E., Harino, S., Shonat, R. D., & Petrig, B. L. (1991). Flicker
evoked increase in optic nerve head blood ﬂow in anesthetized cats.
Neuroscience Letters, 128, 291–296.
Riva, C. E., Grunwald, J. E., Sinclair, S. H., & Petrig, B. L. (1985).
Blood velocity and volumetric ﬂow rate in human retinal vessels.
Investigative Ophthalmology and Visual Science, 26, 1124–1132.
Roden, M., Perseghin, G., Petersen, K. F., Hwang, J. H., Cline, G. W.,
Gerow, K., Rothman, D. L., & Shulman, G. I. (1996). The roles of
insulin and glucagon in the regulation of hepatic glycogen synthesis
and turnover in humans. Journal of Clinical Investigation, 97, 642–
648.
Scheiner, A. J., Riva, C. E., Kazahaya, K., & Petrig, B. L. (1994).
Eﬀect of ﬂicker on macular blood ﬂow assessed by the blue ﬁeld
simulation technique. Investigative Ophthalmology and Visual
Science, 35, 3436–3441.
Schmetterer, L., & Wolzt, M. (1999). Ocular blood ﬂow and associated
functional deviations in diabetic retinopathy. Diabetologia, 42,
387–405.
Sinclair, S. H., Grunwald, J. E., Riva, C. E., Braunstein, S. N.,
Nichols, C. W., & Schwartz, S. S. (1982). Retinal vascular
autoregulation in diabetes mellitus. Ophthalmology, 89, 748–750.
Sullivan, P. M., Davies, G. E., Caldwell, G., Morris, A. C., & Kohner,
E. M. (1990). Retinal blood ﬂow during hyperglycemia. A laser
Doppler velocimetry study. Investigative Ophthalmology and Visual
Science, 31, 2041–2045.
Van Toi, V., & Riva, C. E. (1995). Variations of blood ﬂow at optic
nerve head induced by sinusoidal ﬂicker stimulation in cats. Journal
of Physiology, 482, 189–202.
Vilser, W., Riemer, T., Br€auer-Burchardt, C. H., M€unch, K., Senﬀ, I.,
Kleen, W., Bachmann, K., Pietscher, S., Lang, G. E., & Lang, G.
K. (1997). Retinal vessel analyzer, a new measuring system for
examination of local and temporal vessel behavior. Investigative
Ophthalmology and Visual Science, 38, S105.
Wang, L., & Bill, A. (1997). Eﬀects of constant and ﬂickering light on
retinal metabolism in rabbits. Acta Ophthalmologica Scandinavica,
75, 227–231.
Wang, L., Kondo, M., & Bill, A. (1997). Glucose metabolism in cat
outer retina. Eﬀects of light and hyperoxia. Investigative Ophthal-
mology and Visual Science, 38, 48–55.
1500 G.T. Dorner et al. / Vision Research 43 (2003) 1495–1500
